Etomidate Improves Antitumor Immunity by Suppressing PD-L1 Expression in Hepatocellular Carcinoma CellsSummary

Background & Aims: Etomidate, a prevalent intravenous anesthetic agent, has been implicated in the attenuation of tumorigenesis. Our recent investigations elucidated its capacity to impede the malignant progression of hepatocellular carcinoma (HCC). This study aims to elucidate how etomidate mod...

詳細記述

書誌詳細

主要な著者:	Jiali Xu, Qing Ji, Yining Chen, Yu Xu, Zhihui Wang, Zhenyu Yuan, Dapeng Gao, Lidong Zhang, Cunming Liu, Qing Li, Liren Zhang, Jingjing Dai
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2026-01-01
シリーズ:	Cellular and Molecular Gastroenterology and Hepatology
主題:	Anesthetic Immunosuppression Immunotherapy JAK/STAT Tumor Microenvironment
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2352345X25001936
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!